Shopping Cart 0
Cart Subtotal
USD 0

Acerus Pharmaceuticals Corp (ASP) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Acerus Pharmaceuticals Corp (ASP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation develops, manufactures, markets and distributes novel innovative branded products. It focuses in the therapeutic areas of women's health (female sexual dysfunction, harmone replacement therapy) and men's health (urology). The company's products include Estrace, for menopausal symptoms and Natesto, a testosterone for male hypogonadism. Acerus pipeline products include Tefina, Stendra, Gynoflor, Elegant and Lidbree indicated for various health issues related to men and women. The company sells products through its salesforce in Canada and licensed distributors in the US and other countries. Acerus is headquartered in Mississauga, Ontario, Canada.

Acerus Pharmaceuticals Corp Key Recent Developments

May 13,2019: Acerus reports first quarter 2019 financial results

Mar 05,2019: Acerus reports fourth quarter and full year 2018 financial results

Nov 06,2018: Acerus reports third quarter 2018 financial results

Oct 30,2018: Acerus announces executive leadership changes in corporate finance

Aug 13,2018: Acerus Reports second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Acerus Pharmaceuticals Corp-Key Facts

Acerus Pharmaceuticals Corp-Key Employees

Acerus Pharmaceuticals Corp-Key Employee Biographies

Acerus Pharmaceuticals Corp-Major Products and Services

Acerus Pharmaceuticals Corp-History

Acerus Pharmaceuticals Corp-Company Statement

Acerus Pharmaceuticals Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Acerus Pharmaceuticals Corp-Business Description

Acerus Pharmaceuticals Corp-Corporate Strategy

Acerus Pharmaceuticals Corp-SWOT Analysis

SWOT Analysis-Overview

Acerus Pharmaceuticals Corp-Strengths

Acerus Pharmaceuticals Corp-Weaknesses

Acerus Pharmaceuticals Corp-Opportunities

Acerus Pharmaceuticals Corp-Threats

Acerus Pharmaceuticals Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Acerus Pharmaceuticals Corp, Recent Deals Summary

Section 5-Company's Recent Developments

May 13, 2019: Acerus reports first quarter 2019 financial results

Mar 05, 2019: Acerus reports fourth quarter and full year 2018 financial results

Nov 06, 2018: Acerus reports third quarter 2018 financial results

Oct 30, 2018: Acerus announces executive leadership changes in corporate finance

Aug 13, 2018: Acerus Reports second quarter 2018 financial results

Jun 05, 2018: Acerus Announces Resignation Of Luc Mainville As Director

May 29, 2018: Acerus Acquires Canadian Rights to Novel Pain Relief Product for Gynecological Procedures from Pharmanest

May 15, 2018: Acerus Reports First Quarter 2018 Financial Results

Apr 23, 2018: Acerus Secures Additional CDN USD 2M under the Quantius Loan Facility

Apr 10, 2018: Acerus Announces Settlement of Melnyk Litigation

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Acerus Pharmaceuticals Corp, Performance Chart (2014-2018)

Acerus Pharmaceuticals Corp, Ratio Charts

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Acerus Pharmaceuticals Corp, Key Facts

Acerus Pharmaceuticals Corp, Key Employees

Acerus Pharmaceuticals Corp, Key Employee Biographies

Acerus Pharmaceuticals Corp, Major Products and Services

Acerus Pharmaceuticals Corp, History

Acerus Pharmaceuticals Corp, Subsidiaries

Acerus Pharmaceuticals Corp, Key Competitors

Acerus Pharmaceuticals Corp, Ratios based on current share price

Acerus Pharmaceuticals Corp, Annual Ratios

Acerus Pharmaceuticals Corp, Annual Ratios (Cont...1)

Acerus Pharmaceuticals Corp, Annual Ratios (Cont...2)

Acerus Pharmaceuticals Corp, Interim Ratios

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Acerus Pharmaceuticals Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Acerus Pharmaceuticals Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Allergan Plc

Upsher-Smith Laboratories Inc

Merck Canada Inc

Paladin Labs Inc.

Amgen Canada Inc

Invaron Pharmaceuticals Inc

Acerus Pharmaceuticals Corp (ASP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation develops, manufactures, markets and distributes novel innovative branded products. It focuses in the therapeutic areas of women's health (female sexual dysfunction, harmone replacement therapy) and men's health (urology). The company's products include Estrace, for menopausal symptoms and Natesto, a testosterone for male hypogonadism. Acerus pipeline products include Tefina, Stendra, Gynoflor, Elegant and Lidbree indicated for various health issues related to men and women. The company sells products through its salesforce in Canada and licensed distributors in the US and other countries. Acerus is headquartered in Mississauga, Ontario, Canada.

Acerus Pharmaceuticals Corp Key Recent Developments

May 13,2019: Acerus reports first quarter 2019 financial results

Mar 05,2019: Acerus reports fourth quarter and full year 2018 financial results

Nov 06,2018: Acerus reports third quarter 2018 financial results

Oct 30,2018: Acerus announces executive leadership changes in corporate finance

Aug 13,2018: Acerus Reports second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Acerus Pharmaceuticals Corp-Key Facts

Acerus Pharmaceuticals Corp-Key Employees

Acerus Pharmaceuticals Corp-Key Employee Biographies

Acerus Pharmaceuticals Corp-Major Products and Services

Acerus Pharmaceuticals Corp-History

Acerus Pharmaceuticals Corp-Company Statement

Acerus Pharmaceuticals Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Acerus Pharmaceuticals Corp-Business Description

Acerus Pharmaceuticals Corp-Corporate Strategy

Acerus Pharmaceuticals Corp-SWOT Analysis

SWOT Analysis-Overview

Acerus Pharmaceuticals Corp-Strengths

Acerus Pharmaceuticals Corp-Weaknesses

Acerus Pharmaceuticals Corp-Opportunities

Acerus Pharmaceuticals Corp-Threats

Acerus Pharmaceuticals Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Acerus Pharmaceuticals Corp, Recent Deals Summary

Section 5-Company's Recent Developments

May 13, 2019: Acerus reports first quarter 2019 financial results

Mar 05, 2019: Acerus reports fourth quarter and full year 2018 financial results

Nov 06, 2018: Acerus reports third quarter 2018 financial results

Oct 30, 2018: Acerus announces executive leadership changes in corporate finance

Aug 13, 2018: Acerus Reports second quarter 2018 financial results

Jun 05, 2018: Acerus Announces Resignation Of Luc Mainville As Director

May 29, 2018: Acerus Acquires Canadian Rights to Novel Pain Relief Product for Gynecological Procedures from Pharmanest

May 15, 2018: Acerus Reports First Quarter 2018 Financial Results

Apr 23, 2018: Acerus Secures Additional CDN USD 2M under the Quantius Loan Facility

Apr 10, 2018: Acerus Announces Settlement of Melnyk Litigation

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Acerus Pharmaceuticals Corp, Performance Chart (2014-2018)

Acerus Pharmaceuticals Corp, Ratio Charts

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Acerus Pharmaceuticals Corp, Key Facts

Acerus Pharmaceuticals Corp, Key Employees

Acerus Pharmaceuticals Corp, Key Employee Biographies

Acerus Pharmaceuticals Corp, Major Products and Services

Acerus Pharmaceuticals Corp, History

Acerus Pharmaceuticals Corp, Subsidiaries

Acerus Pharmaceuticals Corp, Key Competitors

Acerus Pharmaceuticals Corp, Ratios based on current share price

Acerus Pharmaceuticals Corp, Annual Ratios

Acerus Pharmaceuticals Corp, Annual Ratios (Cont...1)

Acerus Pharmaceuticals Corp, Annual Ratios (Cont...2)

Acerus Pharmaceuticals Corp, Interim Ratios

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Acerus Pharmaceuticals Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Acerus Pharmaceuticals Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Allergan Plc

Upsher-Smith Laboratories Inc

Merck Canada Inc

Paladin Labs Inc.

Amgen Canada Inc

Invaron Pharmaceuticals Inc